Since synergistic effects of innate and adaptive immunity are beneficial for the induction of anti-tumor immunity and especially for immunological memory [67] it should also be the aim to activate both CD8+ T cells via DCs and NK cells for therapy of selected breast cancer types. Here, CD8A is linked to breast carcinoma.